140 related articles for article (PubMed ID: 16139569)
1. Evaluation of platelet parameters in healthy apheresis donors using the ADVIA 120.
Ifran A; Haşimi A; Kaptan K; Nevruz O; Beyan C; Erbil K
Transfus Apher Sci; 2005 Oct; 33(2):87-90. PubMed ID: 16139569
[TBL] [Abstract][Full Text] [Related]
2. Quality and safety of platelet apheresis concentrates produced with a new leukocyte reduction system.
Riggert J; Humpe A; Simson G; Köhler M
Vox Sang; 1998; 74(3):182-8. PubMed ID: 9595646
[TBL] [Abstract][Full Text] [Related]
3. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers.
Arnold DM; Heddle NM; Kulczycky M; Carruthers J; Sigouin C; Blajchman MA
Transfusion; 2006 Feb; 46(2):257-64. PubMed ID: 16441604
[TBL] [Abstract][Full Text] [Related]
4. Hemoglobin and platelet count effect on platelet yields in plateletpheresis.
Guerrero-Rivera S; Gutiérrez-Espíndola G; Talavera JO; Meillón-García LA; Pedraza-Echevarría M; Pizzuto-Chávez J
Arch Med Res; 2003; 34(2):120-3. PubMed ID: 12700007
[TBL] [Abstract][Full Text] [Related]
5. Function and morphology of platelets produced for transfusion by intermittent-flow centrifugation plateletpheresis or combined platelet-leukapheresis.
Maguire LC; Henriksen RA; Strauss RG; Stein MN; Goedken MM; Echternacht B; Koepke JA; Thompson JS
Transfusion; 1981; 21(1):118-23. PubMed ID: 6162254
[TBL] [Abstract][Full Text] [Related]
6. Platelet apheresis affects prothrombin time and plasminogen levels in healthy donors.
Beyan C; Kaptan K; Savaşçi S; Ifran A; Oztürk Y; Okmen B
Transfus Apher Sci; 2005 Aug; 33(1):47-50. PubMed ID: 15953764
[TBL] [Abstract][Full Text] [Related]
7. Hyperactivation of platelets in asthma and introduction of platelet apheresis as treatment procedure.
Chuchalin AG; Tatarsky AR; Emirova AS; Bobkov EV; Tkachuk VA; Lebedin YS
Z Erkr Atmungsorgane; 1990; 174(3):178-84. PubMed ID: 2399743
[TBL] [Abstract][Full Text] [Related]
8. Effects of the blood-collection tube material and long-term storage on platelet activation parameters on the ADVIA 120/2120 hematology system.
Van Cott EM; Fletcher SR; Kratz A
Lab Hematol; 2005; 11(1):71-5. PubMed ID: 15790555
[TBL] [Abstract][Full Text] [Related]
9. Effect of plateletpheresis on complete blood count values using three different cell separator systems in healthy donors.
Beyan C; Cetin T; Kaptan K; Nevruz O
Transfus Apher Sci; 2003 Aug; 29(1):45-7. PubMed ID: 12877892
[TBL] [Abstract][Full Text] [Related]
10. [Statistical analysis of parameters which determine yield in continuous centrifugal plateletpheresis].
Hühn A; Sachs V; Dörner R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):277-81. PubMed ID: 2475408
[TBL] [Abstract][Full Text] [Related]
11. [Use of plateletpheresis in the treatment of bronchial asthma].
Tatarskiĭ AR; Emirova AS; Bobkov EV; Chuchalin AG
Ter Arkh; 1991; 63(3):90-3. PubMed ID: 2063345
[TBL] [Abstract][Full Text] [Related]
12. Successful removal of Chlamydia pneumoniae from plateletpheresis products collected using automated leukoreduction hemapheresis techniques.
Webley W; Stuart E; Cirino F; Cahill F; Stec T; Andrzejewski C
J Clin Apher; 2006 Oct; 21(3):195-201. PubMed ID: 16570261
[TBL] [Abstract][Full Text] [Related]
13. Generation of reticulated platelets in response to whole blood donation or plateletpheresis.
Gyongyossy-Issa MI; Miranda J; Devine DV
Transfusion; 2001 Oct; 41(10):1234-40. PubMed ID: 11606821
[TBL] [Abstract][Full Text] [Related]
14. Apheresis platelets: emerging issues related to donor platelet count, apheresis platelet yield, and platelet transfusion dose.
Goodnough LT; Kuter D; McCullough J; Brecher ME
J Clin Apher; 1998; 13(3):114-9. PubMed ID: 9828021
[TBL] [Abstract][Full Text] [Related]
15. Biocompatibility studies of the single-needle technique in plateletpheresis with the Fresenius AS 104 blood cell separator.
Moog R; Kadar J; Müller N; Reiser M; Weisswange T; Ledermann AE
Beitr Infusionsther Transfusionsmed; 1994; 32():334-8. PubMed ID: 9422117
[TBL] [Abstract][Full Text] [Related]
16. Economic impact of donor platelet count and platelet yield in apheresis products: relevance for emerging issues in platelet transfusion therapy.
Goodnough LT; Ali S; Despotis G; Dynis M; DiPersio JF
Vox Sang; 1999; 76(1):43-9. PubMed ID: 9933853
[TBL] [Abstract][Full Text] [Related]
17. The content of the LRS chamber provides a new quality tool for the characterization of the donor platelet profile.
Vasconcelos E; Sousa AP; Seghatchian J; Maurício R; Figueiredo AC; Leitão C; Sousa G
Transfus Apher Sci; 2005 Apr; 32(2):221-5. PubMed ID: 15784457
[TBL] [Abstract][Full Text] [Related]
18. rHuG-CSF increases the platelet-neutrophil complex formation and neutrophil adhesion molecule expression in volunteer granulocyte and stem cell apheresis donors.
Karadogan C; Karadogan I; Bilgin AU; Undar L
Ther Apher Dial; 2006 Apr; 10(2):180-6. PubMed ID: 16684221
[TBL] [Abstract][Full Text] [Related]
19. Donor selection criteria to maximize double platelet products (DPP) by platelet apheresis.
Wollersheim J; Dautzenberg M; van de Griendt A; Sybesma B
Transfus Apher Sci; 2006 Apr; 34(2):179-86. PubMed ID: 16574489
[TBL] [Abstract][Full Text] [Related]
20. Successful pregnancy in a young woman with essential thrombocythemia treated with platelet apheresis.
Relakis C; Kyriakou D; Makrigiannakis AS; Kalokyri I; Datseris G; Coumantakis E; Eliopoulos GD
Haematologia (Budap); 1996; 27(4):197-200. PubMed ID: 14651220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
